Get the Stockscreener App
32.30
1.19%
0.38
Pre-market:
32.55
0.25
+0.77%
Zai Lab Limited Adr stock is traded at $32.30, with a volume of 506.97K.
It is up +1.19% in the last 24 hours and down -9.60% over the past month.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
See More
Previous Close:
$31.92
Open:
$31.97
24h Volume:
506.97K
Relative Volume:
0.65
Market Cap:
$3.61B
Revenue:
$418.33M
Net Income/Loss:
$-252.07M
P/E Ratio:
-13.46
EPS:
-2.4
Net Cash Flow:
$-238.84M
1W Performance:
+2.57%
1M Performance:
-9.60%
6M Performance:
-15.45%
1Y Performance:
+56.19%
1-Day Range:
$31.68
$32.48
1-Week Range:
$26.66
$33.06
52-Week Range:
$20.17
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Name
Zai Lab Limited Adr
Sector
Industry
Phone
862161632588
Address
4560 JINKE ROAD, SHANGHAI
Compare ZLAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
32.30 | 3.55B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Resumed | Jefferies | Buy |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-14-23 | Initiated | Morgan Stanley | Overweight |
| Aug-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-22 | Initiated | Macquarie | Outperform |
| Oct-12-21 | Initiated | Bernstein | Mkt Perform |
| Apr-28-20 | Initiated | Goldman | Buy |
| Apr-15-20 | Initiated | Guggenheim | Buy |
| Jul-12-19 | Initiated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
| Jan-29-19 | Initiated | Credit Suisse | Outperform |
| Nov-21-18 | Initiated | Jefferies | Buy |
| Jun-21-18 | Resumed | Leerink Partners | Outperform |
| Feb-14-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-16-17 | Initiated | JP Morgan | Neutral |
| Oct-16-17 | Initiated | Leerink Partners | Outperform |
View All
Zai Lab Limited Adr Stock (ZLAB) Latest News
Insider Buying: Zai Lab (NASDAQ:ZLAB) Insider Purchases 10,000 Shares of Stock - MarketBeat
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives $56.35 Average PT from Brokerages - Defense World
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Woodline Partners LP Sells 558,781 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Zai Lab Limited ADR (NASDAQ: ZLAB) Is Up 14.37% – Is It Capable Of A Rally? - stocksregister.com
Zai Lab (NASDAQ:ZLAB) Shares Gap UpHere's What Happened - MarketBeat
Zai Lab (NASDAQ:ZLAB) Shares Gap DownHere's Why - MarketBeat
FY2026 EPS Estimates for Zai Lab Reduced by Leerink Partnrs - MarketBeat
Market Sentiment Around Loss-Making Zai Lab Limited (NASDAQ:ZLAB) - 富途牛牛
Raymond James Financial Inc. Boosts Holdings in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Cubist Systematic Strategies LLC Increases Stake in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback - Benzinga
Zai Lab FY2026 EPS Forecast Lowered by Leerink Partnrs - Defense World
Zai Lab (NASDAQ:ZLAB) Shares Down 5.8%Here's What Happened - MarketBeat
MPM Bioimpact LLC Acquires 33,659 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Zai Lab Limited Unsponsored ADR $ZLAB - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab LimitedZLAB - FinancialContent
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce… - inkl
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Zai Lab: to await results of Fortitude-102 prior to reg. filing - AInvest
Zai Lab Limited Unsponsored ADR $ZLAB Shares Sold by Russell Investments Group Ltd. - MarketBeat
First ADC Therapy for Cervical Cancer: Zai Lab's TIVDAK Gets Hong Kong Regulatory Green Light - Stock Titan
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong - Business Wire
Zai Lab Limited Unsponsored ADR $ZLAB Shares Purchased by Invesco Ltd. - Defense World
How high can Zai Lab Limited Depositary Receipt stock goTrade Signal Summary & Risk Adjusted Buy and Sell Alerts - Newser
Zai Lab Announces Participation in Investor Conferences in June 2025 - FinancialContent
Zai Lab Limited Depositary Receipt stock chart pattern explained2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser
Can trapped investors hope for a rebound in Zai Lab Limited Depositary Receipt2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
Should you hold or exit Zai Lab Limited Depositary Receipt now2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Predicting Zai Lab Limited Depositary Receipt trend using moving averagesProduct Launch & Reliable Price Action Trade Plans - Newser
Price momentum metrics for Zai Lab Limited Depositary Receipt explainedJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Nuveen LLC Makes New $3.27 Million Investment in First Advantage Co. $FA - Defense World
Zai Lab Announces Participation in Investor Conferences in September 2025 - The Globe and Mail
Russell Investments Group Ltd. Sells 193,978 Shares of Zai Lab Limited Unsponsored ADR $ZLAB - Defense World
Zai Lab to Participate in Investor Conferences in September 2025 - AInvest
Amazon.com, Inc. $AMZN Shares Purchased by Woodard & Co. Asset Management Group Inc. ADV - Defense World
Twelve Points Wealth Management LLC Has $3.93 Million Stock Position in Apple Inc. $AAPL - Defense World
Beacon Bridge Wealth Partners LLC Increases Holdings in Amazon.com, Inc. $AMZN - Defense World
Vanguard Group Inc. Has $33.65 Million Stock Holdings in MGP Ingredients, Inc. $MGPI - Defense World
Charles Schwab Investment Management Inc. Has $6.05 Million Stock Position in SPDR S&P 600 Small Cap Value ETF $SLYV - Defense World
Cornerstone Planning Group LLC Has $6.06 Million Stock Position in Apple Inc. $AAPL - Defense World
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - MSN
Zai Lab (NASDAQ:ZLAB) Now Covered by Jefferies Financial Group - Defense World
Zai Lab Limited Depositary Receipt stock volume spike explainedJuly 2025 Short Interest & Long-Term Growth Plans - Newser
Is Zai Lab Limited Depositary Receipt stock technically oversold2025 Performance Recap & Smart Swing Trading Alerts - theviewers.co.kr
Zai Lab (NASDAQ:ZLAB) Trading Down 5.9% on Insider Selling - Defense World
134,000 Annual Cases: Zai Lab's Innovative Cancer Device TTFields Fast-Tracked in China for Pancreatic Cancer - Stock Titan
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer - Business Wire
What recovery options are there for Zai Lab Limited Depositary Receipt2025 Short Interest & Reliable Price Action Trade Plans - Newser
Why Zai Lab Limited Depositary Receipt is moving todayExit Point & Intraday High Probability Setup Alerts - Newser
Zai Lab Establishes Oncology Scientific Advisory Board - Lelezard
Zai Lab Limited Adr Stock (ZLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):